Think we need clarity on the recent vax results. In particular, were the 15 non-placebo results released for participants that had received all boosters and follow-up shots? If so, is there any reason to expect that results will improve for these 15 by the time the final results are released? Seems to me (and to the market based on the share price) that these results are only marginally better than competitors and pretty disappointing compared to expectations.
Also, are partnership discussions underway? Do they anticipate strong interest once final vax results released?
Questions for AGM?, page-3
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $294.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |